What Is Bemotrizinol (BEMT) and How Does It Compare to Existing Sunscreen Filters?

Bemotrizinol (BEMT) — chemically known as Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine — is a broad-spectrum organic UV filter that absorbs both UVA and UVB radiation. The FDA approved it on June 9, 2026 as the first new active sunscreen ingredient added to the U.S. over-the-counter monograph since the late 1990s. Permitted at concentrations up to 6%, it carries the FDA's "Generally Recognized As Safe and Effective" (GRASE) designation for adults and children six months of age and older.

The approval ended a 27-year drought in U.S. sunscreen innovation. While formulators in Japan can choose from more than 30 approved UV filters, American cosmetic chemists had been working with just 16 active ingredients — only eight of which are in common use — before BEMT arrived. The ingredient is manufactured by DSM-Firmenich (which submitted the OTC Monograph Order Request under the name DSM Nutritional Products LLC) and marketed by BASF under the trade name Tinosorb® S, having been developed originally by Ciba Specialty Chemicals. DSM spent roughly $20 million and two decades navigating the U.S. regulatory process to bring it to market.

How Does BEMT Compare to Other Common Sunscreen Filters?

The table below places BEMT alongside the filters most commonly found in U.S. sunscreens today, using data from the FDA approval record and published formulation science.

Filter	UV Range Covered	Absorption Peaks	Skin Absorption	Photostability	U.S. Max Concentration	Notable Limitation
Bemotrizinol (BEMT)	UVA + UVB	~310 nm & ~340 nm	<1% of applied dose	High (photostable)	6%	New to U.S. market; limited long-term U.S. consumer data
Avobenzone	UVA	~360 nm	Detectable in bloodstream	Low (degrades in sunlight)	3%	Requires photostabilizer (e.g., BEMT itself)
Oxybenzone	UVA + UVB	~288 nm & ~325 nm	High systemic absorption	Moderate	6%	Endocrine-disruption concerns; Hawaii reef ban
Zinc Oxide (mineral)	UVA + UVB	Broad scatter	Minimal (nano-particle debate)	Very high	25%	White cast; heavier texture
Titanium Dioxide (mineral)	UVB + short UVA	Broad scatter	Minimal	Very high	25%	Weaker UVA coverage; white cast
Octinoxate	UVB	~311 nm	Detectable in bloodstream	Moderate	7.5%	No UVA protection; Hawaii reef ban
Homosalate	UVB	~306 nm	Detectable in bloodstream	Moderate	15%	Narrow UVB-only coverage

Sources: FDA final order, BASF Tinosorb S announcement, FDA clinical overview documentation.

What Exactly Is Bemotrizinol and How Does It Work?

Bemotrizinol is a triazine-based organic UV filter with the molecular formula C₃₈H₄₉N₃O₅ and a molecular weight of 627.81 g/mol. Its large molecular structure — molar volume of 565.7 cm³ — is a key reason it stays near the surface of the skin rather than penetrating deeply into the body.

BEMT works by absorbing UV photons and releasing the captured energy as heat, rather than allowing it to damage skin cells or DNA. What sets it apart from older chemical filters is its dual absorption profile: one peak at approximately 310 nm (UVB territory) and a second at approximately 340 nm (UVA territory). Most single-mechanism filters cover only one of these ranges effectively. Avobenzone, for example, peaks around 360 nm and covers UVA well but provides no meaningful UVB protection on its own. Octinoxate peaks at 311 nm and handles UVB but leaves UVA entirely unaddressed.

BEMT's dual-peak architecture means a single ingredient can anchor a genuinely broad-spectrum formula, reducing the number of additional actives a chemist needs to stack. Cosmetic chemist Kelly Dobos, writing for Allure, notes this allows formulators to "use lower overall levels of actives while still meeting high SPF and UVA protection targets."

Why Did It Take So Long for BEMT to Reach the U.S. Market?

The delay is rooted in how the U.S. regulates sunscreen. In most of the world — Europe, Japan, Australia — sunscreen is classified as a cosmetic, which means new filters can be approved through a relatively simplified process. In the United States, sunscreen is regulated as an over-the-counter drug, subject to the same rigorous safety and efficacy standards as pharmaceutical products.

Before the CARES Act reformed the OTC monograph system, adding a new active ingredient required navigating a decades-long regulatory pathway that effectively froze the approved list. BASF notes that BEMT is the first new UV filter approved by the FDA in 27 years. DSM spent approximately $20 million and 20 years pursuing U.S. approval, per Allure's reporting.

The CARES Act changed the mechanics by establishing a simplified administrative order process for OTC monograph drugs. DSM submitted an OTC Monograph Order Request, the FDA proposed the addition in December 2025, accepted public comments through January 26, 2026, and issued the final order on June 9, 2026 — seven months from proposal to approval. That speed is itself a signal of how the reformed process is meant to work.

FDA Commissioner Marty Makary, M.D., M.P.H., was direct about the agency's prior failures: "The agency has historically moved too slowly in this area, leaving Americans with fewer options than consumers abroad."

Is BEMT Safe? What Does the Absorption Data Show?

Safety is where BEMT distinguishes itself most sharply from several existing chemical filters. The FDA's concern about older chemical sunscreens — oxybenzone, avobenzone, octinoxate, and others — is well documented: studies have shown these ingredients absorb into the bloodstream at concentrations that exceed the FDA's threshold for waiving additional safety studies.

BEMT's pharmacokinetic profile is strikingly different. FDA clinical documentation shows that in pharmacokinetic studies, both dermal and oral dosing routes resulted in very low systemic exposure — not exceeding 1% of the applied dose — with over 98% of the radiolabeled material recovered as the unmetabolized parent compound. In vitro percutaneous penetration tests using human skin membranes showed no penetration into the receptor fluid, and the absorbed dose was below 0.6% of the applied dose.

The FDA's nonclinical summary attributes this low absorption to BEMT's large molecular structure. Rat skin was approximately 6–10 times more permeable to BEMT than human skin, meaning animal studies likely overestimate real-world human absorption. In vitro metabolism testing using human liver enzymes produced no phase I or phase II metabolites, suggesting BEMT does not break down into harmful byproducts in the body.

The FDA's final designation: GRASE — generally recognized as safe and effective — for adults and children six months and older, with the agency noting it "rarely causes skin irritation."

MD Anderson dermatologist Susan Chon, M.D., put it plainly in a July 2026 review: "If we can avoid exposure to more of these things, and we have other alternatives, such as sunscreens with bemotrizinol, we should take advantage of that."

How Does BEMT Perform as a Photostabilizer?

One of BEMT's underappreciated roles in formulation is as a photostabilizer for other UV filters. Avobenzone — the primary UVA filter available in the U.S. — is notoriously photounstable. It degrades rapidly under intense sunlight, losing meaningful UVA protection within hours of application unless paired with a stabilizing agent.

BASF's technical documentation confirms that Tinosorb S (BEMT) "is a photostabilizer within sunscreen formulations for more photo-unstable UV filters" and specifically "helps stabilize ingredients such as avobenzone, improving the durability and effectiveness of UVA protection in complex formulations." This is not a minor benefit: a formula combining BEMT with avobenzone can deliver more reliable UVA protection throughout the day than an avobenzone-only formula, even at lower total active concentrations.

BEMT also supports formulas in achieving a critical wavelength above 370 nm — the threshold the FDA uses to designate a sunscreen as "broad spectrum" — when combined with avobenzone or zinc oxides. This makes it a versatile anchor ingredient rather than just an add-on.

What Are the Formulation Advantages for Skin Feel and Texture?

For consumers who have avoided chemical sunscreens because of greasiness or white cast, BEMT offers a meaningful improvement on both fronts.

Because BEMT is highly efficient at absorbing UV radiation, formulators can achieve high SPF and UVA protection targets with lower total concentrations of active ingredients. Fewer actives generally means a lighter, less occlusive base — which translates to better skin feel. Cosmetic chemist Kelly Dobos told Allure that BEMT enables "products with lighter texture and less greasiness in formulations."

Unlike mineral filters such as zinc oxide and titanium dioxide, BEMT is an organic (carbon-based) molecule that dissolves into the formula rather than sitting on top of the skin as a physical barrier — no white cast. MD Anderson's review highlights this as a key advantage: "unlike mineral sunscreens, it doesn't leave a white cast." That matters especially for people with deeper skin tones who have historically found mineral sunscreens cosmetically unacceptable.

Which Products Currently Contain BEMT in the U.S.?

As of September 2026, three products containing BEMT have reached U.S. shelves, all arriving within weeks of each other. Each pairs BEMT with established filters rather than relying on BEMT alone.

Ultra Violette's Unblock Screen SPF 50 Breakout-Friendly Skinscreen ($40) combines BEMT with zinc oxide in a semi-matte formula designed for oily and acne-prone skin. The zinc-BEMT pairing is notable: zinc provides mineral broad-spectrum coverage while BEMT adds photostability and boosts UVA performance without adding heaviness.

Neutrogena launched two BEMT products simultaneously. The Clear Face Sunscreen Acne-Prone Skin Broad Spectrum SPF 60 ($19) and the Ultra Sheer Daily Face Sunscreen Broad Spectrum SPF 70 ($19, with added peptides and antioxidants) both pair BEMT with avobenzone, octisalate, and homosalate. The avobenzone-BEMT combination is particularly well-suited to the U.S. market because it addresses avobenzone's photostability weakness directly — BEMT stabilizes avobenzone, extending the effective UVA protection window throughout the day.

More products are expected to follow as formulators gain access to the ingredient and consumer demand builds.

What Do Dermatologists and Medical Institutions Say About BEMT?

The professional medical community has been broadly supportive. The American Academy of Dermatology (AAD) had been advocating for expanded sunscreen options for years before the approval. Susan C. Taylor, MD, FAAD, the immediate past president of the AAD, stated in December 2025 that "the United States lags behind many other countries that have nearly twice as many approved sunscreen ingredients," and welcomed the BEMT proposal as a step toward closing that gap. The AAD's position is grounded in public health data: one in five Americans will develop skin cancer in their lifetime.

MD Anderson's Susan Chon, M.D., described the approval as significant for patient care: "We can finally offer an alternative sunscreen that more people may be willing to use. The features of this sunscreen are really attractive." Her emphasis on willingness to use is important — the most effective sunscreen is the one a person will actually apply consistently. If lighter texture and no white cast increase compliance, the public health benefit compounds.

HHS Secretary Robert F. Kennedy, Jr. framed the approval in terms of market competition and consumer confidence, noting that "bemotrizinol has been used safely in Europe for decades." The ingredient's long track record in the EU, Australia, and Japan means the global safety data set is substantial, even if U.S.-specific long-term data is still accumulating.

Who Should Consider Switching to a BEMT-Containing Sunscreen?

BEMT is not a mandatory upgrade — existing broad-spectrum sunscreens with SPF 30 or higher remain effective when applied correctly. That said, several groups stand to benefit most from BEMT-containing formulas.

People with oily or acne-prone skin who have struggled with the heaviness of mineral sunscreens or the greasiness of older chemical formulas may find BEMT-based products more tolerable. The lighter texture that BEMT enables — demonstrated in the Ultra Violette and Neutrogena launches — is a direct response to this complaint.

People with darker skin tones who avoid mineral sunscreens due to white cast now have a chemical option that offers genuine broad-spectrum coverage without the cosmetic downside. BEMT's transparency on skin is comparable to other organic filters.

People concerned about systemic absorption of chemical sunscreen ingredients have a compelling reason to consider BEMT. Its absorption rate of less than 1% of the applied dose stands in stark contrast to the bloodstream concentrations documented for oxybenzone and avobenzone. The long-term health implications of those higher-absorption filters remain uncertain; BEMT's profile removes much of that uncertainty.

Anyone currently using an avobenzone-based sunscreen may also benefit from switching to a formula that includes BEMT as a photostabilizer, since BEMT extends the effective UVA protection window that avobenzone alone cannot sustain through a full day of sun exposure.

What Comes Next for Sunscreen Innovation in the U.S.?

The BEMT approval is explicitly positioned as the beginning of a broader regulatory modernization, not a one-off event. Karen Murry, M.D., Director of the Office of Nonprescription Drugs at FDA, stated that the agency looks "forward to working with other companies on bringing products containing other new active ingredients to market for a wide array of conditions in multiple therapeutic areas, in a much more timely fashion than was possible in the past."

BEMT is the first new active ingredient added to an OTC monograph under the simplified CARES Act process, and the seven-month timeline from proposal to final order demonstrates that the new framework can move at a pace that was previously impossible. Other filters widely used in Europe and Asia — including Tinosorb M (bisoctrizole), Mexoryl SX (ecamsule), and Mexoryl XL (drometrizole trisiloxane) — have been pending U.S. consideration for years and may now have a clearer path forward.

For consumers, the practical implication is that the U.S. sunscreen market is likely to look meaningfully different within the next few years. Formulas that were previously impossible to replicate domestically — the ultra-light, high-SPF, no-white-cast sunscreens common in South Korea and Japan — become achievable as more filters gain approval. If you've been curious about Japanese sun protection routines, the gap between what's available there and what's available here is starting to close.

BEMT represents the most significant advancement in U.S. sunscreen science in nearly three decades. Its combination of dual-peak broad-spectrum coverage, photostability, low skin absorption, and formulation versatility makes it a genuinely useful addition to the chemist's toolkit — and a meaningful option for consumers who want effective sun protection without the trade-offs that have historically come with it.

If you're building or refining a sun protection routine, pairing a BEMT-containing sunscreen with other protective measures — broad-spectrum SPF 30 or higher, protective clothing, and limiting peak-hour sun exposure — remains the evidence-based standard. BEMT makes that routine easier to stick to, and that may be its most important contribution.